Skip to main content

Deguelin, an Akt Inhibitor, Down-Regulates NF-κB Signaling and Induces Apoptosis in Colon Cancer Cells and Inhibits Tumor Growth in Mice

Digestive Diseases and Sciences volume 57, pages 2873–2882 (2012)Cite this article

Abstract

Background

Deguelin, a naturally occurring rotenoid, is known to be an Akt inhibitor and to have an anti-tumor effect on several cancers.

Aims

This study was performed to elucidate the effect of deguelin on apoptotic pathways related to NF-κB signaling in colon cancer cells and on the anti-tumor effect in colon cancer xenograft mice.

Methods

We studied COLO 205 and HCT116 cells in the presence or absence of deguelin. NF-κB signaling was examined by real-time RT-PCR for interleukin (IL)-8, by Western blotting for IκB phosphorylation/degradation, and by the electrophoretic mobility shift assay. Cell death was determined by the MTT assay, and apoptosis by Annexin V-FITC staining and caspase-3 activity. We also assessed the expression of antiapoptotic and proapoptotic factors by use of RT-PCR. In colon cancer xenograft mice, we evaluated the effect of deguelin on inoculated tumor growth, and apoptotic index was measured by the in vivo TUNEL assay.

Results

Deguelin significantly inhibited IL-8 gene expression, IκB phosphorylation/degradation, and DNA binding activity of NF-κB in colon cancer cells. Deguelin induced cell death and apoptosis in colon cancer cells in a dose and time-dependent manner. Deguelin down-regulated expression of NF-κB-mediated antiapoptotic factors such as cFLIP, Bcl-2, and Bcl-XL. In the colon cancer xenograft model, the volume of the tumor treated with deguelin was significantly lower than that of the control, and the apoptotic index for deguelin-treated mice was much higher.

Conclusion

Deguelin might be a potential therapeutic agent for treatment of colorectal cancer.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Byeon JS, Yang SK, Kim TI, et al. Colorectal neoplasm in asymptomatic Asians: a prospective multinational multicenter colonoscopy survey. Gastrointest Endosc. 2007;65:1015–1022.

    PubMed  Article  Google Scholar 

  2. Abbruzzese JL, Lippman SM. The convergence of cancer prevention and therapy in early-phase clinical drug development. Cancer Cell. 2004;6:321–326.

    CAS  PubMed  Article  Google Scholar 

  3. Aggarwal BB, Takada Y, Oommen OV. From chemoprevention to chemotherapy: common targets and common goals. Expert Opin Investig Drugs. 2004;13:1327–1338.

    CAS  PubMed  Article  Google Scholar 

  4. Lee HY, Oh SH, Woo JK, et al. Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis. J Natl Cancer Inst. 2005;97:1695–1699.

    CAS  PubMed  Article  Google Scholar 

  5. Udeani GO, Gerhauser C, Thomas CF, et al. Cancer chemopreventive activity mediated by deguelin, a naturally occurring rotenoid. Cancer Res. 1997;57:3424–3428.

    CAS  PubMed  Google Scholar 

  6. Gerhauser C, Lee SK, Kosmeder JW, et al. Regulation of ornithine decarboxylase induction by deguelin, a natural product cancer chemopreventive agent. Cancer Res. 1997;57:3429–3435.

    CAS  PubMed  Google Scholar 

  7. Chun KH, Kosmeder JW II, Sun S, et al. Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells. J Natl Cancer Inst. 2003;95:291–302.

    CAS  PubMed  Article  Google Scholar 

  8. Lee HY, Suh YA, Kosmeder JW, et al. Deguelin-induced inhibition of cyclooxygenase-2 expression in human bronchial epithelial cells. Clin Cancer Res. 2004;10:1074–1079.

    CAS  PubMed  Article  Google Scholar 

  9. Gerhauser C, Mar W, Lee SK, et al. Rotenoids mediate potent cancer chemopreventive activity through transcriptional regulation of ornithine decarboxylase. Nat Med. 1995;1:260–266.

    CAS  PubMed  Article  Google Scholar 

  10. Murillo G, Salti GI, Kosmeder JW 2nd, et al. Deguelin inhibits the growth of colon cancer cells through the induction of apoptosis and cell cycle arrest. Eur J Cancer. 2002;38:2446–2454.

    CAS  PubMed  Article  Google Scholar 

  11. Greten FR, Eckmann L, Greten TF, et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004;118:285–296.

    CAS  PubMed  Article  Google Scholar 

  12. Kucharczak J, Simmons MJ, Fan Y, et al. To be, or not to be: NF-kappaB is the answer–role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene. 2003;22:8961–8982.

    CAS  PubMed  Article  Google Scholar 

  13. Cho SJ, Kim JS, Kim JM, et al. Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice. Int J Cancer. 2008;123:951–957.

    CAS  PubMed  Article  Google Scholar 

  14. Kim JM, Kang HW, Cha MY, et al. Novel guggulsterone derivative GG-52 inhibits NF-kappaB signaling in intestinal epithelial cells and attenuates acute murine colitis. Lab Invest. 2010;90:1004–1015.

    CAS  PubMed  Article  Google Scholar 

  15. Lee JY, Kim JS, Kim JM, Kim N, Jung HC, Song IS. Simvastatin inhibits NF-kappaB signaling in intestinal epithelial cells and ameliorates acute murine colitis. Int Immunopharmacol. 2007;7:241–248.

    CAS  PubMed  Article  Google Scholar 

  16. Nam SY, Kim JS, Kim JM, et al. DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis. Exp Biol Med. 2008;233:180–191.

    CAS  Article  Google Scholar 

  17. Cheon JH, Kim JS, Kim JM, et al. Plant sterol guggulsterone inhibits nuclear factor-kappaB signaling in intestinal epithelial cells by blocking IkappaB kinase and ameliorates acute murine colitis. Inflamm Bowel Dis. 2006;12:1152–1161.

    PubMed  Article  Google Scholar 

  18. Jobin C, Hellerbrand C, Licato LL, et al. Mediation by NF-kappa B of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors. Gut. 1998;42:779–787.

    CAS  PubMed  Article  Google Scholar 

  19. Murillo G, Kosmeder JW 2nd, Pezzuto JM, et al. Deguelin suppresses the formation of carcinogen-induced aberrant crypt foci in the colon of CF-1 mice. Int J Cancer. 2003;104:7–11.

    CAS  PubMed  Article  Google Scholar 

  20. Nair AS, Shishodia S, Ahn KS, et al. Deguelin, an Akt inhibitor, suppresses IkappaBalpha kinase activation leading to suppression of NF-kappaB-regulated gene expression, potentiation of apoptosis, and inhibition of cellular invasion. J Immunol. 2006;177:5612–5622.

    CAS  PubMed  Google Scholar 

  21. Karin M, Yamamoto Y, Wang QM. The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov. 2004;3:17–26.

    CAS  PubMed  Article  Google Scholar 

  22. Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell. 2003;114:181–190.

    CAS  PubMed  Article  Google Scholar 

  23. Fang LW, Tai TS, Yu WN, et al. Phosphatidylinositide 3-kinase priming couples c-FLIP to T cell activation. J Biol Chem. 2004;279:13–18.

    CAS  PubMed  Article  Google Scholar 

  24. Huang S, Pettaway CA, Uehara H, et al. Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene. 2001;20:4188–4197.

    CAS  PubMed  Article  Google Scholar 

  25. Udeani GO, Zhao GM, Shin YG, et al. Pharmacokinetics of deguelin, a cancer chemopreventive agent in rats. Cancer Chemother Pharmacol. 2001;47:263–268.

    CAS  PubMed  Article  Google Scholar 

Download references

Acknowledgments

This study was supported in part by grant no. 03-2009-0060 from the SNUH Research Fund. The authors thank Chi-Yeon Lim, Ph.D., for her assistance with statistics.

Conflict of interest

The authors have no conflict of interest.

Author information

Affiliations

  1. Department of Internal Medicine, Dongguk University Ilsan Hospital, Seoul, Korea

    Hyoun Woo Kang

  2. Department of Microbiology and Institute of Biomedical Science, Hanyang University College of Medicine, Seoul, Korea

    Jung Mogg Kim

  3. Department of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine, 28 Yongon-Dong, Chongno-Gu, Seoul, 110-744, South Korea

    Mi Yeon Cha, Hyun Chae Jung, In Sung Song & Joo Sung Kim

Authors
  1. Hyoun Woo Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jung Mogg Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mi Yeon Cha
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hyun Chae Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. In Sung Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Joo Sung Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joo Sung Kim.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kang, H.W., Kim, J.M., Cha, M.Y. et al. Deguelin, an Akt Inhibitor, Down-Regulates NF-κB Signaling and Induces Apoptosis in Colon Cancer Cells and Inhibits Tumor Growth in Mice. Dig Dis Sci 57, 2873–2882 (2012). https://doi.org/10.1007/s10620-012-2237-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-012-2237-x

Keywords

  • Deguelin
  • Colon cancer
  • NF-κB
  • Apoptosis